Defining Musical Toxicity and Its Effect on Patient Well-being
NCT ID: NCT06494046
Last Updated: 2025-06-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2024-08-15
2025-05-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Tumor Resection Guided by Intraoperative Indocyanine Green Dye Fluorescence Angiography in Patients With Sarcoma
NCT06409013
The Microbiome in Blood Cancer and HLH
NCT06734624
An Integrative Multi-Omic Characterization of Head and Neck Carcinogenesis, Progression and Recurrence
NCT06420219
Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care (Interception for Suspected Lung Cancer)
NCT06482073
A Study of Live Tumor Fragments of Surgical Resections
NCT07000864
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I. Describe specific musical difficulties that arise during and after cancer treatments: define "musical toxicity".
II. Discover any interventions or treatments which musicians found helpful while going through cancer treatment.
III. Investigate whether the priority of playing music changed through the course of cancer treatment and beyond, in relation to other priorities including cancer cure and length of life.
IV. Discover treatment and cancer related factors which are correlated with worse musical toxicity.
OUTLINE: This is an observational study. Patients are assigned to 1 of 2 groups.
MUSICAL TOXICITY GROUP: Patients complete a questionnaire, participate in an interview and have their medical records reviewed on study.
NO MUSICAL TOXICITY GROUP: Patients have their medical records reviewed on study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Observational Musical Toxicity Group
Patients complete a questionnaire, participate in an interview and their medical records reviewed on study.
Non-Interventional Study
Non-Interventional Study
Observational No Musical Toxicity Group
Patients have their medical records reviewed on study.
Non-Interventional Study
Non-Interventional Study
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Non-Interventional Study
Non-Interventional Study
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Active or accomplished musicians
* Those performing in the community as part of a group or as a soloist
* Those teaching lessons in an individual or group setting
* Those for whom music teaching or performance is a primary source of income
* Those who play music multiple times per week
* Our ideal cohort will consist of an equal number of patients with the following malignancies above the diaphragm:
* Brain
* Head and Neck
* Esophagus or Lung
* Breast
* Our ideal cohort will consist of an equal number of patients who engage in the following musical endeavors:
* Stringed instruments
* Wind instruments (including woodwind and brass instruments)
* Keyboard instruments
* Vocalists
Exclusion Criteria
* Did not regularly attempt to engage in musical endeavors during or after cancer treatment
* Not willing or able to complete the questionnaire or engage in a one-hour interview (i.e. limited English proficiency)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mayo Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dean A. Shumway, M.D.
Role: PRINCIPAL_INVESTIGATOR
Mayo Clinic in Rochester
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mayo Clinic in Rochester
Rochester, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Mayo Clinic Clinical Trials
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2024-05423
Identifier Type: REGISTRY
Identifier Source: secondary_id
23-012760
Identifier Type: OTHER
Identifier Source: secondary_id
ROR2333
Identifier Type: OTHER
Identifier Source: secondary_id
ROR2333
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.